immunoproteasome inhibitors (Principia)

N/A

Report date: 2025/01/26 17:50:07
NME

Base Information

Drug Nameimmunoproteasome inhibitors (Principia)
Drug Alias Nameimmunoproteasome inhibitors (Principia/AbbVie)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrincipia Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrincipia Biopharma Inc
Inactive CompaniesAbbvie Inc
Active IndicationsAutoimmune DiseasesPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A